Skip to main content

Table 4 Particle size, PDI, zeta potential, and encapsulation efficiency of liposomes

From: Combination therapy with lipid prodrug liposomes reshapes disease-associated neutrophils to promote the cancer-immunity cycle

Liposomes

PEG2, 5 K@MLP-L

HA*SAS@DXP-L

Phospholipids (mg)

HSPC: 70, EPG: 30

DOTAP: 60, HSPC: 4

Material (mg)

mPEGn-DSPE: 70

SAS: 12, HA: 3

CH (mg)

5

5

Drug (mg)

MLP: 7.5

DXP: 7.5

Particle size (nm)

99.8 ± 2.1

101.7 ± 4.7

PDI

0.074 ± 0.014

0.076 ± 0.009

Zeta potential (mV)

− 73.2 ± 0.7

− 17.6 ± 0.6

Encapsulation efficiency (%)

98.4 ± 0.8

98.3 ± 0.9

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us